Shiang Y. Lim

Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore.

Necrostatin: a potentially novel cardioprotective agent?

Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury.

Activation of protease activated receptor-2 induces delayed cardioprotection in anesthetized mice.

The novel adipocytokine visfatin exerts direct cardioprotective effects.

The cannabinoid CB1 receptor antagonist, rimonabant, protects against acute myocardial infarction.

Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning.

Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury.

The neural and humoral pathways in remote limb ischemic preconditioning.

Absence of the inhibitory G-protein Galphai2 predisposes to ventricular cardiac arrhythmia.

Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure.

Failure of the adipocytokine, resistin, to protect the heart from ischemia-reperfusion injury.

Rapid assessment of myocardial infarct size in rodents using multi-slice inversion recovery late gadolinium enhancement CMR at 9.4T.

In vivo tissue engineering chamber supports human induced pluripotent stem cell survival and rapid differentiation.

Ischemic preconditioning promotes intrinsic vascularization and enhances survival of implanted cells in an in vivo tissue engineering model.

Enrichment of neonatal rat cardiomyocytes in primary culture facilitates long-term maintenance of contractility in vitro.

Hypoxic conditioning enhances the angiogenic paracrine activity of human adipose-derived stem cells.

Trichostatin A enhances differentiation of human induced pluripotent stem cells to cardiogenic cells for cardiac tissue engineering.

Growing vascularized heart tissue from stem cells.

Ischemic preconditioning for cell-based therapy and tissue engineering.

Efficient generation of integration-free human induced pluripotent stem cells from keratinocytes by simple transfection of episomal vectors.

HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore.

Enhancing Human Cardiomyocyte Differentiation from Induced Pluripotent Stem Cells with Trichostatin A.

Cardiac Repair with a Novel Population of Mesenchymal Stem Cells Resident in the Human Heart.

Defined Medium Conditions for the Induction and Expansion of Human Pluripotent Stem Cell-Derived Retinal Pigment Epithelium.

Electrical Stimulation Promotes Cardiac Differentiation of Human Induced Pluripotent Stem Cells.

Three Dimensional Collagen Scaffold Promotes Intrinsic Vascularisation for Tissue Engineering Applications.

Harnessing the secretome of cardiac stem cells as therapy for ischemic heart disease.

Minicircle DNA-mediated endothelial nitric oxide synthase gene transfer enhances angiogenic responses of bone marrow-derived mesenchymal stem cells.

Study of mitochondrial respiratory defects on reprogramming to human induced pluripotent stem cells.

Melatonin Protects Human Adipose-Derived Stem Cells from Oxidative Stress and Cell Death.